September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Rho GTPase-mediated activation of the MAP kinase pathway facilitates TGF-β2 dependent ET-1 expression
Author Affiliations & Notes
  • Cynthia Lynn Pervan
    Research Service, Edward Hines Jr. VA Hospital, Hines, Illinois, United States
    Ophthalmology, Loyola University Chicago, Maywood, Illinois, United States
  • Jonathan Lautz
    Research Service, Edward Hines Jr. VA Hospital, Hines, Illinois, United States
    Program in Neuroscience, Loyola University Chicago, Maywood, Illinois, United States
  • Evan B Stubbs
    Research Service, Edward Hines Jr. VA Hospital, Hines, Illinois, United States
    Ophthalmology, Loyola University Chicago, Maywood, Illinois, United States
  • Footnotes
    Commercial Relationships   Cynthia Pervan, None; Jonathan Lautz, None; Evan Stubbs, None
  • Footnotes
    Support  Supported, in part, by grants from the Department of Veterans Affairs (C7506M and I21RX001593 to CLP; C3638R, B3756-F & I21RX001553 to EBS), 1R21NS08542 to EBS, the Midwest Eye-Banks, the Illinois Society for the Prevention of Blindness, and the Richard A. Peritt Charitable Foundation.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4687. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Cynthia Lynn Pervan, Jonathan Lautz, Evan B Stubbs; Rho GTPase-mediated activation of the MAP kinase pathway facilitates TGF-β2 dependent ET-1 expression. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4687.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Elevated content of transforming growth factor (TGF)-β2 and endothelin-1 (ET-1) within the aqueous humor of affected patients is associated with the development of primary open-angle glaucoma (POAG). We have previously demonstrated that TGF-β2 markedly enhances ET-1 expression and secretion in human trabecular meshwork (TM) cells through concurrent activation of both canonical (Smad3) and non-canonical (Rho GTPase) signaling pathways. Here, we elucidate the mechanism by which Rho GTPases promote TGF-β2 mediated induction of ET-1 expression in human TM cells.

Methods : Confluent human TM cells were cultured in serum-free media and incubated x 24h in the absence (vehicle) or presence of TGF-β2 (5 ng/ml). In some experiments, Rho GTPase dependent signaling was blocked by pre-treatment with exoenzyme C3 transferase or siRNA-targeted knockdown of RhoA or RhoB. p38 dependent MAP kinase signaling was inhibited by pre-treatment with SB-203580. Content of RhoA, RhoB, or total and phosphorylated p38 proteins were determined by Western immunoblot. Relative changes in preproendothelin (ppET)-1 mRNA content and secreted ET-1 peptide were quantified by real-time PCR and ELISA, respectively.

Results : Human TM cells pretreated (1h) with SB-203580 exhibit a significant attenuation of TGF-β2 mediated ET-1 induction. Pretreating TM cells with exoenzyme C3 transferase (1h), or with siRNA targeting RhoA, similarly attenuates TGF-β2 mediated ET-1 induction. Consistent with these findings, TGF-β2 was found to elicit a marked increase in acute (30 min) phosphorylation of p38 MAP kinase. By comparison, pre-treatment with exoenzyme C3 transferase (1h) modestly attenuates TGF-β2 mediated acute phosphorylation of p38 MAP kinase.

Conclusions : TGF-β2 induction of ET-1 expression in human TM cells is mediated by RhoA GTPase dependent activation of p38 MAP kinase signaling.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×